Abstract:T-cell antigen receptors (TCRs) exhibit inherent cross-reactivity which broadens the spectrum of epitopes that are recognizable by a finite TCR-repertoire but also carries the risk of autoimmunity. However, TCRs support also a high level of antigen specificity as they allow T-cells to discriminate single antigenic peptide/MHC complexes (pMHCs) against millions of structurally related self-pMHCs, in some cases based on the absence or presence of a single methyl-group. How TCRs manage to convey such seemingly contrary properties and why some T-cells become over time autoreactive despite negative thymic selection, has remained elusive. Here, we devised a non-invasive molecular live cell imaging platform to investigate the biophysical parameters governing stimulatory TCR:pMHC interactions in settings of autoreactivity and anti-viral responses - two extremes in T-cell antigen recognition. We show that CMV-specific CD8+ RA14-T-cells respond effectively to even a single HLA-A2/CMV (A2/CMV) antigen, with synaptic TCR:pMHC lifetimes lasting seconds. In contrast, cross-reactivity of type 1 diabetes (T1D)-associated CD8+ 1E6 T-cells towards HLA-A2/preproinsulin (A2/PPI) self-epitopes involved ten-fold less stable synaptic TCR interactions resulting in severely attenuated ZAP70 recruitment and downstream signaling. Compared to A2/CMV-engaged RA14 T-cells, 1E6-T-cells required for activation 4000 or more A2/PPI and at least 100-times as many simultaneously pMHC-engaged TCRs. In support of antigen discrimination, CD8 co-engagement of MHC class I (MHCI) strengthened both settings of TCR:pMHC interactions equally but was essential only for sensitized virus detection but not autorecognition (1000- versus 5-fold enhancement). We conclude that the binding dynamics of TCRs and CD8 with pMHC shape the boundaries of central tolerance in the physiological context of the phenomenal yet also differential T-cell antigen detection capacity, TCR-cross-reactivity and self-antigen abundance. Gained insights are integral to a molecular and quantitative understanding of CD8+ T-cell mediated autoimmunity and protective immunity against infections and cancer.

Innate Autoreactive B Cells As Antigen-Presenting Cells in the Induction of Tolerance to Conserved Keratin Polypeptide

Presentation of an Endogenous MHC Class Ⅰ Restricted Autoantigen by Keratinocytes in Vitro

Antigen presentation for central tolerance induction

Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self

Decoration of T-independent Antigen with Ligands for CD22 and Siglec-G Can Suppress Immunity and Induce B Cell Tolerance in Vivo

T Cells Specific for Post-Translational Modifications Escape Intrathymic Tolerance Induction

The Interplay Between Innate-Like B Cells and Other Cell Types in Autoimmunity

Human autoreactive T cells recognize CD1b and phospholipids

Correction: Antigen-presenting Autoreactive B Cells Activate Regulatory T Cells and Suppress Autoimmune Arthritis in Mice

Antigen presentation by B cells enables epitope spreading across an MHC barrier

Reduced Self-Reactivity of an Autoreactive T Cell After Activation with Cross-reactive Non–Self-Ligand

Deconstructing CTL-mediated autoimmunity through weak TCR-cross-reactivity towards highly abundant self-antigen

Novel MHC-Independent αβTCRs Specific for CD48, CD102, and CD155 Self-Proteins and Their Selection in the Thymus

B cell-reactive triad of B cells, follicular helper and regulatory T cells at homeostasis

Autoreactivity in an HIV-1 Broadly Reactive Neutralizing Antibody Variable Region Heavy Chain Induces Immunologic Tolerance

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity

Specific Immune Tolerance of Antigen-Presenting Cells: Hypothesis and Significance.

Recognition of Self and Altered Self by T Cells in Autoimmunity and Allergy

CTLA-4 expression by B-1a B cells is essential for immune tolerance

Characterization Of Autoreactive And Bystander Il-17(+) T Cells Induced In Immunized C57bl/6 Mice

Repetitive Antigen Responses of LDL-Reactive CD4+ T Cells Induce Tr1 Cell–Mediated Immune Tolerance